Source link : https://newshealth.biz/health-news/rifaximin-lowers-hepatic-encephalopathy-risk-in-cirrhosis/
TOPLINE: Rifaximin significantly reduces the risk for hepatic encephalopathy (HE) in patients with cirrhosis, with greater effectiveness observed with longer treatment durations. METHODOLOGY: Rifaximin is recommended as an add-on therapy to lactulose for preventing the recurrence of HE, with its efficacy noted in a prior meta-analysis; however, few studies have examined its use for HE […]
The post Rifaximin Lowers Hepatic Encephalopathy Risk in Cirrhosis first appeared on News Health.
—-
Author : News Health
Publish date : 2025-05-29 07:23:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8